Treating Opioid Use Disorder: A Pharmacist’s Guide for Understanding Medication-Assisted Treatment (MAT) | Bethesda, MD (POSTPONED UNTIL FURTHER NOTICE)
5151 Pooks Hill Rd
Bethesda, MD 20814
Opioids use disorder (OUD) is a chronic condition that affects millions of Americans. If left untreated it can result in serious consequences including increased morbidity, relapse, opioid overdose, and death. Medication-assisted treatment is effective for OUD and has been shown to decrease all-cause mortality and opioid overdose-related deaths. This pharmacist-driven training will provide detailed education on the induction and maintenance of medication-assisted treatment for opioid use disorder.
- Discuss the epidemiology of opioid overdose and opioid use disorder in the United States
- Review the prescribing patters of opioids for chronic non-cancer pain over the past two decades
- Define and review the clinical presentation of opioid dependence, opioid withdrawal, and opioid use disorder
- Review the pharmacology and therapeutics for methadone, buprenorphine/naloxone, and naltrexone for the treatment of opioid use disorder
Jasmine Carpenter, Pharm.D, BCPS, BCPP, mental health clinical pharmacist at a hospital in D.C. where she provides direct pharmaceutical care to patients of the mental health service and SUD rehab program. She received her Doctor of Pharmacy from Howard University College of Pharmacy. Upon graduating from Howard University, she completed her Postgraduate Year-1 (PGY-1) Pharmacy Practice Residency at the Washington DC Veterans Affairs (VA) Medical Center. As a Mental Health Clinical Pharmacy Specialist, she provides clinical services and direct psychotropic management to patients receiving mental health and substance/alcohol use disorder services within primary care. Outside of this role, Dr. Carpenter serves as adjunct faculty at Howard University College of Pharmacy and regularly provides psychopharmacology and substance abuse education and training on both a national and international level.
Registration will be available soon.